AssayQuant Technologies, Inc.

A powerful approach for understanding kinase and phosphatase function and identifying the most effective drugs.

[AssayQuant Technologies, Inc. @assayquant]

We’re excited to introduce KinSight Kinome Profiling Services. Learn how profiling with a continuous assay and our detailed enzymological reports provide informative and actionable kinetic insights for your kinase drug discovery https://t.co/PNNFkicL9H

#kinomeprofiling #cancer

[AssayQuant Technologies, Inc. @assayquant]

Context matters. That is why we created PhosphoSens-Lysate Assays –quantitative kinase activity insights where biology happens.

https://t.co/y82cqDT4Im

#KinaseInhibitor

[AssayQuant Technologies, Inc. @assayquant]

Don’t miss Dr. Earl May's panel at the #CellSignalingSymposium!

Date/Time: Feb 19th | 2:55-4:25 PM
Location: Fairmont Hotel Vancouver
Topic: Continuous Enzymatic Assays for Drug Discovery

Connect with us to talk kinase kinetics & PhosphoSens® insights!

#CellSignaling

[AssayQuant Technologies, Inc. @assayquant]

Join Dr. Earl May at the Cell Signaling Symposium on Feb 19 in Vancouver!

Time: 2:55–4:25 PM
Topic: A Continuous Enzymatic Assay Identifies and Characterizes Kinetic Modes of Action to Drive Drug Discovery

Discover the latest in cell signaling research!
https://t.co/FqKuZcelQX

[AssayQuant Technologies, Inc. @assayquant]

Just dropped: PhosphoSens-Lysate Assays - real-time, direct fluorescence intensity measurement of kinase activity in crude cell lysates. Order MAPK1/ERK2 and MAPK3/ERK1 assays now, more targets coming soon!

https://t.co/bgfzh34mgI

#BiotechTools

[AssayQuant Technologies, Inc. @assayquant]

Continuous fluorogenic assays = real-time, quantitative kinase & phosphatase activity insights.

Learn how this add & read technology is accelerating drug discovery at the Kinase Inhibitor Summit on February 11th at 10 am EST with Dr. Erik Schaefer.

#KinaseInhibitorSummit

[AssayQuant Technologies, Inc. @assayquant]

Heading to the Kinase Inhibitor Summit? Don’t miss Dr. Erik Schaefer as he presents: Continuous Fluorogenic Assays for Kinase & Phosphatase Activity to Enable Drug Development

February 11th at 10 am EST | Boston, MA

#KinaseInhibitorSummit #DrugDiscovery

[AssayQuant Technologies, Inc. @assayquant]

Target in focus: ERK1/2 PhosphoSens-Lysate Assays are here to accelerate
your kinase research. More targets coming soon!

https://t.co/ksv7iIsEKz

#BiotechBreakthrough

[AssayQuant Technologies, Inc. @assayquant]

Looking for real-time kinase activity insights in complex samples?

Introducing PhosphoSens-Lysate Assays! Assay MAPK1/ERK2 and MAPK3/ERK1 in their native environments.

Additional targets coming soon. https://t.co/205EbVzL5P

#BiotechInnovation

[AssayQuant Technologies, Inc. @assayquant]

Announcing PhosphoSens-Lysate Assays: Measure kinase activity in real-time, directly in complex biological samples. Available now for MAPK1/ERK2 and MAPK3/ERK1!

https://t.co/y2Kd1LUCK8

#DrugDiscovery

[AssayQuant Technologies, Inc. @assayquant]

Get more accurate kinase activity data with PhosphoSens®. Say goodbye to endpoint assays and hello to complete progress curves!

https://t.co/jHbO0OkNg5

#drugdiscovery #kinase

[AssayQuant Technologies, Inc. @assayquant]

Maximize your resources! PhosphoSens® reduces the need for multiple assays, saving you time and money.

Learn more: https://t.co/K2XpwpSAUq

#drugdiscovery #technology #assay

[AssayQuant Technologies, Inc. @assayquant]

Tired of compound interference in your kinase assays PhosphoSens®-Red's red-shifted fluorescence minimizes interference for cleaner HTS data.
Learn more!
https://t.co/UhNqcTF3kI

#SLAS2025 #drugdiscovery #kinase

[AssayQuant Technologies, Inc. @assayquant]

Happy Holidays from Assay Quant. We’re celebrating with Kinome Trees! Transform complex kinase inhibition data into clear, publication-ready visualizations.

https://t.co/Lzt7ZYGOHt

[AssayQuant Technologies, Inc. @assayquant]

Three steps to perfect (and festive) kinome trees:
1. Upload data
2. Choose theme
3. Generate & export

Happy Holidays from Assay Quant!

https://t.co/icgETKPDDK

[AssayQuant Technologies, Inc. @assayquant]

It’s the perfect time of year to create, customize, and download high-resolution kinome trees for your next publication or presentation.

Get started for free: https://t.co/E4thn2X2rW

#SciComm

[AssayQuant Technologies, Inc. @assayquant]

Endpoint assays do not reveal saturation kinetics. Saturation analysis can identify slow-binding or irreversible inhibition and quantify potency specific to that inhibitor type.  

See what you could be missing: https://t.co/1MNte5N96a

#drugdiscovery #kinaseinhibitors

[AssayQuant Technologies, Inc. @assayquant]

Are you able to recognize saturation in your progress curves? 

Endpoint assays do not reveal saturation kinetics. With a continuous assay, you can identify and diagnose saturation in your progress curves.

See what you could be missing: https://t.co/b71nPCL3y5

[AssayQuant Technologies, Inc. @assayquant]

Create your own beautiful, customizable kinome trees in minutes. Our free gift to you this Holiday Season: https://t.co/zc2GzLUMrE

#SciComm

[AssayQuant Technologies, Inc. @assayquant]

Are you missing progress curve lags?

Lag times can expose issues and provide critical insights. Endpoint assays miss them and underestimated potency. 

Learn how continuous assays expose lag time and provide critical insights for #drugdiscovery: https://t.co/2XOuubUgsh

[AssayQuant Technologies, Inc. @assayquant]

What’s more festive than a Kinome Tree?! Zoom into specific kinase families for detailed analysis or view the complete kinome landscape.

https://t.co/azqUJJOtoD

#SciComm